UK markets open in 7 hours 52 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.20 +0.25 (+0.32%) GOLD FUTURES
2,313.40 +3.80 (+0.16%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,322.11 +1,197.56 (+2.60%)
Codexis Inc (4QK.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
At close: 08:04AM CEST
| Previous close | 2.7960 |
| Open | 2.8460 |
| Bid | 3.1060 x 0 |
| Ask | 3.1320 x 0 |
| Day's range | 2.8460 - 2.8460 |
| 52-week range | 1.4040 - 4.2220 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Codexis Inc (CDXS) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic Advances
Despite a Net Loss, Codexis Demonstrates Strong Revenue Growth and Strategic Milestones
GlobeNewswireCodexis Reports First Quarter 2024 Financial Results
Q1 Total Revenue Up 32% Year-over-year, Including Product Revenue Up 14%; Company Reiterates 2024 Financial Guidance First Substantial Order for dsRNA Ligase Received from Large Pharma Customer Company is in Final Stages of Enzymatically Synthesizing a Full-Length Oligonucleotide with ECO Synthesis™ Manufacturing Platform and will Provide Update at TIDES USA Meeting REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today an
Simply Wall St.With 74% institutional ownership, Codexis, Inc. (NASDAQ:CDXS) is a favorite amongst the big guns
Key Insights Given the large stake in the stock by institutions, Codexis' stock price might be vulnerable to their...
© 2024 Yahoo. All rights reserved.